Macrophage Polarization and Insulin Resistance: PPARγ in Control

Cell Metabolism

Volumn 6, Issue 2, 2007, Pages 96-98

  Charo, Israel F ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CELL POLARITY; CELL TRANSFORMATION; DRUG FATALITY; FOAM CELL; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; IN VITRO STUDY; INFLAMMATION; INFLAMMATORY CELL; INSULIN RESISTANCE; MACROPHAGE; MONOCYTE; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CELL POLARITY; HUMANS; INSULIN RESISTANCE; MACROPHAGES; MICE; MONOCYTES; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 34547469630     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.07.006     Document Type: Short Survey

References (23)

1. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. Nat. Med. 11 (2005) 191-198
2. Babaev V.R., Yancey P.G., Ryzhov S.V., Kon V., Breyer M.D., Magnuson M.A., Fazio S., and Linton M.F. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1647-1653
3. Barlic J., Zhang Y., Foley J.F., and Murphy P.M. Circulation 114 (2006) 807-819
4. Boring L., Gosling J., Cleary M., and Charo I.F. Nature 394 (1998) 894-897
5. Bouhlel M.A., Derudas B., Rigamonti E., Dièvart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., et al. Cell Metab. 6 (2007) 137-143 this issue
6. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., and Evans R.M. Nat. Med. 7 (2001) 48-52
7. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., et al. Mol. Cell 7 (2001) 161-171
8. Gordon S. Nat. Rev. Immunol. 3 (2003) 23-35
9. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., and Rollins B.J. Mol. Cell 2 (1998) 275-281
10. Han K.H., Chang M.K., Boullier A., Green S.R., Li A., Glass C.K., and Quehenberger O. J. Clin. Invest. 106 (2000) 793-802
11. Hansson G.K., and Libby P. Nat. Rev. Immunol. 6 (2006) 508-519
12. Hevener A.L., Olefsky J.M., Reichart D., Nguyen M.T., Bandyopadyhay G., Leung H.Y., Watt M.J., Benner C., Febbraio M.A., Nguyen A.K., et al. J. Clin. Invest. 117 (2007) 1658-1669
13. Lumeng C.N., Bodzin J.L., and Saltiel A.R. J. Clin. Invest. 117 (2007) 175-184
14. Nissen S.E., and Wolski K. N. Engl. J. Med. 356 (2007) 2457-2471
15. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Eagle A.R., Vats D., Brombacher F., Ferrante A.W., and Chawla A. Nature 447 (2007) 1116-1120
16. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. Nature 437 (2005) 759-763
17. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. Nature 391 (1998) 79-82
18. Shoelson S.E., Lee J., and Goldfine A.B. J. Clin. Invest. 116 (2006) 1793-1801
19. Spiegelman B.M. Diabetes 47 (1998) 507-514
20. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. J. Clin. Invest. 112 (2003) 1796-1808
21. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., and Ferrante Jr. A.W. J. Clin. Invest. 116 (2006) 115-124
22. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. J. Clin. Invest. 112 (2003) 1821-1830
23. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.-W., Karin M., and Shoelson S.E. Science 293 (2001) 1673-1677